The Rho guanine nucleotide exchange factor ARHGEF5 promotes tumor malignancy via epithelial-mesenchymal transition.Published in:Oncogenesis, 2016, v. 5, n. 9, p. e258, doi. 10.1038/oncsis.2016.59By:Komiya, Y;Onodera, Y;Kuroiwa, M;Nomimura, S;Kubo, Y;Nam, J-M;Kajiwara, K;Nada, S;Oneyama, C;Sabe, H;Okada, MPublication type:Article
ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance.Published in:Oncogenesis, 2016, v. 5, n. 9, p. e259, doi. 10.1038/oncsis.2016.60By:Hashimoto, A;Hashimoto, S;Sugino, H;Yoshikawa, A;Onodera, Y;Handa, H;Oikawa, T;Sabe, HPublication type:Article